Analysts Forecast Q1 Revenue of $1.22B, See 15.7% Upside on Alignment Healthcare
Analysts forecast Q1 2026 revenue of $1.22 billion and EPS of $0.01 for Alignment Healthcare, with full-year 2026 revenue estimate trimmed to $5.17 billion from $5.25 billion and EPS raised to $0.14. The average 12-month price target of $25.33 implies a 15.7% upside from $21.90, supported by an Outperform consensus rating of 1.6.
1. Q1 2026 Earnings Estimates
Alignment Healthcare forecasts Q1 revenue of $1.22 billion with EPS of $0.01 and full-year 2026 revenue of $5.17 billion and EPS of $0.14.
2. Estimate Revisions
Over the past 90 days, full-year 2026 revenue estimates fell from $5.25 billion to $5.17 billion and 2027 estimates from $6.63 billion to $6.48 billion, while EPS forecasts rose from $0.10 to $0.14 for 2026 and from $0.32 to $0.37 for 2027.
3. Valuation and Analyst Sentiment
Analysts set a 12-month average price target of $25.33 (range $18–30), implying 15.7% upside from $21.90. Consensus rating stands at 1.6 Outperform and a GuruFocus value of $23.85 suggests 8.9% upside.